VAERS reports by lot

Moderna COVID-19 lot 083B22A: VAERS reports

123 VAERS reports list lot 083B22A as a Moderna COVID-19 vaccine, received between 2022-09-06 and 2024-01-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
123
Reports
3%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1319%
General / Systemic (non-local)1015%
Gastrointestinal913%
Dermatological (non-injection-site)812%
Cardiac / Cardiovascular710%
Musculoskeletal710%
Injection-site / Local reaction57%
Allergic / Anaphylactic34%
Thrombotic / Hematological23%
Respiratory23%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey21
California14
Pennsylvania12
Texas9
Idaho9
Michigan6
Georgia6
North Carolina5
Colorado4
Rhode Island3
Ohio3
Massachusetts3

Reports by month received

2022-0926
2022-1037
2022-1113
2022-1233
2023-012
2023-022
2023-032
2023-052
2023-063
2023-071
2023-101
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.